Search
Menu
Home
HTB
2017
November
24
HTB
24 November 2017
Contents
Antiretrovirals
Coformulated dolutegravir plus rilpivirine approved in US (Juluca)
Darunavir-based single pill FDC approved in EU (Symtuza)
HTB RSS
Early access
Sputnik V vaccine not approved in South Africa due to potential increased risk of HIV
23 October 2021
Gilead withdraws application for F/TAF as PrEP in the EU
21 October 2021
Community “Respect my HIV” march: 30 October 2021 in London
18 October 2021
NHS Scotland approves long-acting cabotegravir and rilpivirine injections
14 October 2021
All early access reports
Current issues
October 2021
September 2021
August 2021
Back issues
Special report
Pipeline report 2021: HIV drugs in development
17 September 2021
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
